Kent Pharma Achieves EcoVadis Gold Rating for the Third Consecutive Year

The Kent-Athlone Pharma Group, a leading and rapidly growing specialty pharmaceutical company operating across UK and Europe, is pleased to announce that Kent Pharma has been awarded the prestigious EcoVadis Gold Rating for the third consecutive year.
Kent Pharma Ecovadis 2026

This achievement highlights the company's commitment to corporate social responsibility and excellence, reflecting the continued integration of sustainable and responsible business practices throughout its operations.

By securing Gold status for a third consecutive year, Kent Pharma remains among the top 5% of companies out of more than 150,000 companies assessed worldwide, demonstrating its ongoing dedication to continuous improvement and responsible growth. 

Importantly, Kent Pharma's overall EcoVadis score increased compared with the previous assessment, reflecting the successful implementation of additional sustainability policies and measures across the organisation. The assessment also recognised the company's advanced sustainability management system, which comprehensively addresses all four themes under review.

This latest recognition further reinforces the Kent-Athlone Pharma Group's position as a trusted and forward-thinking pharmaceutical organisation committed to sustainable growth, operational excellence, and long-term value creation.

Date Published
June 3, 2026
Posted By
Kent Pharma
Share Article
If you require general information concerning one of our products, including availability, please contact our customer services team: